IVERMECTIN AS ADJUVANT TO HYDROXYCHOLOROQUINE IN PATIENTS RESISTANT TO STANDARD TREATMENT FOR SARS-CoV-2: RESULTS OF AN OPEN-LABEL RANDOMIZED CLINICAL STUDY

PARIPEX INDIAN JOURNAL OF RESEARCH (2020) - Comments
doi: 10.36106/paripex/4801859

Naveen Kishoria, S.L Mathur, Veeram Parmar, Rimple Jeet Kaur, Harish Agarwal, B.S Parihar, Somil Verma